^
Association details:
| Biomarker: | STRN-ALK fusion |
|---|---|
| Cancer: | Lung Adenocarcinoma |
| Drug: | Ensacove (ensartinib) (ALK inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report
Published date:
09/21/2022
Excerpt:
...we reported a case of lung adenocarcinomas with brain metastasis, harboring STRN-ALK fusion, responded well to ensartinib.
DOI:
https://doi.org/10.3390/curroncol29100530
